Background: ameloblastoma is a common tumor found in head and neck disorder. The definitive treatment include resection of tumor and reconstruction for filling the large defect which left after tumor resection. The reconstruction option which can be done is flap method. In this case, we used sternocleidomastoid-clavicle myoosseus flap in our patient with post traumatic plate displacement post resection and reconstruction of ameloblastoma. Case: a 22-year-old woman presented with unstability of jaw after hitting her chin to the table since 3 days prior to admission. On 2011, she had history of ameloblastoma which got resected and reconstructed with fibular graft and plate in the same year. While the plate seemed to be broken, she was managed with plate removal and reconstruct with sternocleidomastoid-clavicle myoosseus flap. Post operation, patient managed with gradual diet from liquid to solid. Observation Post Operation Day (POD) 3, flap is vital. Patient is discharged on POD 7 and visit as outpatient every 3-5 days until POD 14. Finally, we remove the suture, operation scar is good, and the flap is vital during one year follow up. Conclusion: sternocleidomastoid-clavicle myoosseus flap is practical and safe procedure, which can be used as alternative option in  mandible reconstruction.

Infantile haemangiomas affect approximately 5% of the population and usually do not require treatment. However, complex cutaneous haemangiomas can cause disabling disfigurement, while haemangiomas in the brain, airway or gastrointestinal tract can cause life-threatening complications. Although children with infantile haemangiomas are often first brought to general practitioners and paediatricians by parents for care, they are thought of as a surgical problem and usually referred to specialty care. We present a case of an infant from a resource-poor setting in rural Indonesia with disfiguring facial haemangiomas, as well as a probable airway haemangioma causing stridor at rest. The infant was treated with oral propranolol with marked involution of the cutaneous haemangioma, resolution of stridor and increase in weight.

No abstract

Background: Febrile neutropenia is a common complication in patient undergoing chemotherapy. Length Of Stay (LOS) is an important marker for disease severity and use of medical resources in febrile neutropenia. This study was done to find the risk factor affecting length of stay in solid cancer patients with febrile neutropenia post neoadjuvant/therapeutic chemotherapy. Method: This is a case control study without matching. Age ≥ 60 years, (Absolute Neutrofil Count) ANC level < 1,5 μL , comorbid, Hb level <10 gr/dl, and albumin < 3 gr/dl, were related to LOS (≤ 5 days and > 5 days). Univariate (chi square) and multivariate Latar Belakang: Febrile neutropenia merupakan komplikasi yang cukup sering didapat pada pasien yang sedang menjalani kemoterapi. Length Of Stay (LOS) merupakan penanda penting untuk derajat keparahan penyakit dan pengeluaran biaya kesehatan pada febrile neutropenia. Penelitian ini dilakukan untuk mencari faktor risiko yang dapat mempengaruhi lama hari perawatan pada pasien kanker solid dengan febrile neutropenia pasca kemoterapi neoadjuvant/terapeutik. Metode: Penelitian ini merupakan studi kasus kontrol tanpa matching. Usia ≥ 60 tahun, Nilai Absolute Neutrofil Count (ANC) < 1,5 μL , komorbid, Hb<10 gr/dl, dan albumin < 3 gr/dl (logistic regression) were used to analyse the statistic. Results: Forty six patients met inclusion-exclusion criteria were included in this study. ANC level in all patients were < 1,5 μL (100%). Hb level <10 gr/dl is statistically significant (P<0.05), whereas age ≥ 60 years, and comorbid, albumin level < 3 gr/dl were not is statistically significant (P>0.05). Conclusion: Hb level < 10 gr/dl is the risk factor for LOS > 5 days in solid cancer patients with febrile neutropenia post neoadjuvant/ therapeutic chemotherapy. dihubungkan dengan lamanya LOS (LOS ≤ 5 hari dan > 5 hari). Analisis penelitian menggunakan analisis univariat (chi square) dan multivariat (regresi logistik) dengan SPSS versi 16. Hasil: Sejumlah 46 pasien memenuhi kriteria inklusi-eksklusi pada studi ini. Nilai ANC pada seluruh sampel penelitian <1,5 μL (100%). Kadar Hb<10 gr/dl bermakna signifikan secara statistik (P<0,05), sedangkan faktor usia ≥ 60 tahun, komorbid, dan albumin < 3 gr/ dl tidak berbeda bermakna (P>0,05). Kesimpulan: Kadar Hb < 10 gr/dl merupakan faktor risiko lamanya LOS > 5 hari pada pasien kanker solid dengan febrile neutropenia paska kemoterapi neoadjuvant/terapeutik.